Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
J C Melchor, A Khalil, D Wing...
https://pubmed.ncbi.nlm.nih.gov/29920825/Actively Recruiting
Led by Ultrasound-Innovation Medtech, S.L. · Updated on 2025-05-13
457
Participants Needed
14
Research Sites
6 weeks
Total Duration
Researchers are evaluating the safety and predictive ability of the Cervisense TPTL device in pregnant women showing symptoms of threatened preterm labor between 28 weeks and 36 weeks plus 6 days of gestation. The study aims to determine if the device can predict spontaneous preterm birth within 7 days and whether it is safe and reliable to use in hospital settings. This includes a Pilot Study with randomized groups and a Pivotal Study with a single group to confirm performance and safety. The trial involves two main study phases. In the Pilot Study, participants are randomly assigned to either receive the standard care or the Cervisense evaluation, which uses an intravaginal probe to measure cervical stiffness combined with clinical data by an algorithm. The Pivotal Study is a larger, single-arm phase where all participants receive the Cervisense evaluation. The main procedures include intravaginal measurements using the Cervisense Intravaginal Probe and comparison with transvaginal ultrasound cervicometry in the Pilot Study. Participants will be monitored from enrollment until delivery and followed for 14 days after the cervical assessment to track delivery outcomes and any adverse events. Researchers will assess the devices ability to predict preterm birth, monitor labor progression, record any trauma or pain related to device use, and collect feedback on technical reliability and operator satisfaction. Safety is closely observed with independent committees reviewing adverse events throughout the study period.
CONDITIONS
FB-CT2 Includes Two Prospective, Multi-centre Studies With a Medical Device in Hospital Settings: a Randomized, Dual-arm, Open-label Pilot Study in Spain, Followed by a Single-arm, Non-randomized, Open-label International Pivotal Study
A
Alberto Maroto Ferrer
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ultrasound-Innovation Medtech, S.L.
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From enrollment until delivery
Participants undergo cervical stiffness evaluation using the Cervisense Intravaginal Probe and receive standard care or cervicometry measured with transvaginal ultrasound depending on study arm assignment. This phase includes device use and monitoring for safety and technical performance.
Visits occur as needed during hospital stay until delivery
Duration - 14 days post-delivery or post-device use
Participants are monitored for labour progression and trauma indicators, including pain and adverse events, for 14 days after delivery or device use.
Approximately 1 to 2 follow-up visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
2
Have more questions? Get in touch with our team for quick support
J C Melchor, A Khalil, D Wing...
https://pubmed.ncbi.nlm.nih.gov/29920825/E Papiernik, J Bouyer, D Collin...
https://pubmed.ncbi.nlm.nih.gov/3945433/W L Holcomb, J S Smeltzer
https://pubmed.ncbi.nlm.nih.gov/2047066/M Parra-Saavedra, L Gómez, A Barrero...
https://pubmed.ncbi.nlm.nih.gov/21465603/J C Melchor, H Navas, M Marcos...
https://pubmed.ncbi.nlm.nih.gov/28850753/G M Jackson, J Ludmir, T J Bader
https://pubmed.ncbi.nlm.nih.gov/1731287/Antonio Callejas, Antonio Gomez, Inas H Faris...
https://pubmed.ncbi.nlm.nih.gov/31349721/E H BISHOP
https://pubmed.ncbi.nlm.nih.gov/14199536/Francisca Sonia Molina, Laura Pardo, Maria D Muñoz...
https://pubmed.ncbi.nlm.nih.gov/37094638/L C Carlson, H Feltovich, M L Palmeri...
https://pubmed.ncbi.nlm.nih.gov/23836486/Ultrasound-Innovation Medtech, S.L.
Lead Sponsor